Few & Far Between: How Biotech Gets Built

Chris O'Brien

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Also on

Recent episodes

  • Episode 74: Jason Tardio, President and COO, Immunic TherapeuticsSep 16, 2026 · 44 min
  • Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc.Aug 11, 2026 · 37 min
  • Episode 72: Joel White, Owner, Marketcap ConsultingJun 22, 2026 · 53 min
  • Episode 71: Chris O'Brien, Former ⁨Biorasi⁩ CEO and Current CEO of ⁨Rancho BiosciencesMay 12, 2026 · 43 min
  • Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical SchoolMar 17, 2026 · 1 hr 2 min
  • Video Episode 68: Sinan Gölhan, CEO at GelTech LabsJan 27, 2026 · 44 min
  • Video Episode 67: Aoife Brennan, President and CEO of Climb BioJan 7, 2026 · 1 hr 12 min
  • Episode 66: Mark Abelson, Founder of Ora ClinicalDec 16, 2025 · 43 min
  • Video Episode 65 - Amit Etkin, Founder and CEO of Alto NeuroscienceNov 24, 2025 · 1 hr 7 min
  • Video Episode 64 - Professor Justin StebbingNov 11, 2025 · 48 min

Website · RSS feed

Few & Far Between: How Biotech Gets Built | Parasocial